Clinical Trial Update: Efficacy and Safety of Lubiprostone in Patients With Irritable Bowel Syndrome With Constipation [Phase 3]

View source ↗

Summary

Phase 3 trial update on Lubiprostone for irritable bowel syndrome with constipation, including efficacy and safety results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome with Constipation

Drugs mentioned

• LUBIPROSTONE (lubiprostone)

Snippet

Sponsor: Sucampo Pharma Americas, LLC | Conditions: Irritable Bowel Syndrome With Constipation | Phase 3 | Status: COMPLETED | Results posted: 2014-02-11